Growing attention to medication safety and personalized treatment is influencing the US Anticholinergic Drugs Market. Healthcare providers are increasingly considering patient characteristics and potential adverse effects when selecting anticholinergic therapies. The Anticholinergic Drugs Market was valued at US$ 8.15 Billion in 2025 and is projected to reach US$ 11.27 Billion by 2034,...